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Eukaryotic gene expression is precisely regulated at all points 
between transcription and translation. In this review, we focus 
on translational control mediated by the 3’-untranslated 
regions (UTRs) of mRNAs. mRNA 3’-UTRs contain cis-acting 
elements that function in the regulation of protein translation 
or mRNA decay. Each RNA binding protein that binds to these 
cis-acting elements regulates mRNA translation via various 
mechanisms targeting the mRNA cap structure, the eukaryotic 
initiation factor 4E (eIF4E)-eIF4G complex, ribosomes, and the 
poly (A) tail. We also discuss translation-mediated regulation 
of mRNA fate. [BMB Reports 2017; 50(4): 194-200]
INTRODUCTION
Translational regulation of mRNA is an immediate and precise 
mechanism to control gene expression in various biological 
processes, including development, differentiation, and 
responses to extracellular stress. Global quantification analysis 
indicates that the cellular abundance of proteins in mammals 
is predominantly controlled at the level of translation (1). In 
vivo, mRNAs do not exist as bare mRNA molecules but as 
mRNA-protein complexes with RNA-binding proteins (RBPs) 
(2-5). More than one thousand RBPs have been identified, and 
they bind to specific cis-acting elements, consisting of 
sequence elements, stem-loop structures and/or modified 
nucleotides (6-8). For many genes, alternative poly (A) addition 
and alternative splicing give rise to 3’-UTR variants (Fig. 1A 
and B). These variants are controlled by specific post- 
transcriptional regulation (9, 10). 
The cap-dependent mRNA translational process is divided 
into three major steps: initiation, elongation, and termination. 
Each step is elaborately regulated by multiple mRNA 3’-UTR 
binding proteins in a cell type- and species-specific manner 
(11, 12). In this review, we present examples of RBP-mediated 
regulation of translation and we discuss their biological roles.
MOLECULAR MECHANISM OF CAP-DEPENDENT 
mRNA TRANSLATION BY 3’-UTR BINDING PROTEINS
In eukaryotes, most protein coding mRNAs have a 5’-terminal 
cap structure and a 3’-terminal poly-adenine. Histone mRNAs, 
however, are an exception, having a specific stem-loop 
structure in the 3’-terminal region (13). The cap structure acts 
as an anchor and is critical for translation initiation by the 
eukaryotic initiation complex (14). In eukaryotes, this cap- 
dependent translation initiation is implemented by two 
macromolecular complexes, namely, the eukaryotic initiation 
factor-4F (eIF4F) complex, consisting of eIF4E, eIF4G and 
eIF4A, and the 43S initiation complex, consisting of a 40S 
ribosome, eIF3, eIF1A, eIF2 and methionyl-tRNA (11, 12). The 
eIF4F complex connects the 5’- and 3’-termini of the mRNA 
via interactions with poly(A) binding protein (PABP) or histone 
stem-loop binding protein (SLBP) (13). This mRNA circulariza-
tion plays a significant role in efficient translation, probably by 
accelerating ribosome recycling (Fig. 2A) (11, 12). In addition, 
eukaryotic release factor 3 (eRF3) directly binds to the 
PABP/eIF4G complex and stimulates translation (15). Hence, 
mRNA translation can be modulated by the cap-binding 
protein complex. The circularization of mRNA is also a 
significant molecular feature in the regulation of 
cap-dependent mRNA translation by 3’-UTR RBPs (11, 12).
REGULATION OF TRANSLATION THROUGH THE CAP 
STRUCTURE (Fig. 2B)
The cap-binding protein, eIF4E, is the foundation of a 
translation initiation complex at the 5’-terminal cap structure 
(11, 12). In addition, the eIF4E-related molecule, 4E homo-
logous protein (4EHP), competitively and directly binds the 
cap structure. However, 4EHP represses translation because of 
its weak affinity to eIF4G (16). 4EHP can be recruited by RBPs 
such as Bicoid (which binds to a specific cis-element in the 
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Fig. 1. mRNA processing generates 
3’-UTR variants. (A) Schematic depic-
tions of pre-mRNA and mature mRNA. 
UTR (untranslated region), CDS (protein 
coding sequence), UC-PAS (upstream 
core polyadenylation signal), DC-PAS 
(downstream core polyadenylation 
signal). (B) mRNA isoforms with alterna-
tive poly(A) additions.
3’-UTR of caudal mRNA) and the Pumilio/Nanos/Brat complex 
(which binds to a specific cis-element in the 3’-UTR of 
hunchback mRNA) during Drosophila melanogaster develop-
ment (17, 18). Mammalian 4EHP also has the ability to 
suppress translation via the same mechanisms (19, 20). On the 
other hand, 4EHP can augment translation during hypoxia in 
human U87MG glioblastoma cells (21). The transcription factor, 
hypoxia-Inducible Factor 2 (HIF-2), can bind both DNA and 
RNA and forms a complex with RBM4 on the 3’-UTRs of a 
subset of mRNAs including FGFR mRNA. The HIF-2/RBM4 
complex then recruits 4EHP to stimulate translation. eIF4A, but 
not eIF4G, is present in this complex (21). 
REGULATION OF TRANSLATION THROUGH THE 
eIF4E-eIF4G STRUCTURE (Fig. 2C)
The interaction between eIF4E and eIF4G is required for 
mRNA circularization and the initiation of cap-dependent 
translation (11, 12). D. melanogaster Cup, Xenopus laevis 
Maskin, mammalian Neuroguidin (NGD) and mammalian 
cytoplasmic fragile X mental retardation protein (FMRP) 
interacting protein 1 (CYFIP1) bind eIF4E competitively with 
eIF4G and repress translation. These translational repressors 
are recruited to mRNAs through specific 3’-UTR binding 
proteins, namely, Cup/Bruno, Cup/Smaug, Maskin/cytoplasmic 
polyadenylation element binding protein (CPEB), NGD/CPEB, 
and CYFIP1/FMRP (22-25).
microRNAs (miRNAs) are small RNA molecules consisting 
of 21-24 nucleotides that form microRNA-induced silencing 
complexes (miRISCs) with Argonaute (Ago) proteins and 
repress translation. Ago proteins have isoform specific 
mechanisms for repression of translation. In D. melanogaster, 
after miRISC binds to a miRNA target site in an mRNA 3’-UTR, 
Ago2 represses translation by competing for eIF4E binding, 
which is similar to Cup (26). 
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Fig. 2. Translational control by 3’-UTR
binding proteins. (A) Schematic depiction 
of circularized mRNA translation. (B) 
Regulation of translation through the cap 
structure. (C) Regulation of translation 
through the eIF4E-eIF4G complex. (D) 
Regulation of translation through the 43S 
translation initiation complex. (E) 
Regulation of translation through the 80S 
ribosome assembly. (F) Regulation of 
translation through translation elongation. 
(G) Regulation of translation through the 
poly(A) tail.
REGULATION OF TRANSLATION THROUGH THE 43S 
TRANSLATION INITIATION COMPLEX (Fig. 2D)
In contrast to D. melanogaster Ago2, D. melanogaster Ago1 
and vertebrate Ago2 repress translation by interfering with the 
assembly of a functional eIF4F complex. This occurs through 
the displacement of eIF4A (in vertebrate eIF4A1 and eIF4A2) 
from the mRNA, leading to the functional suppression of the 
43S initiation complex (27, 28). A conflicting model of 
vertebrate Ago2 action has been proposed. In this model, the 
vertebrate Ago-associated CCR4-NOT complex recruits eIF4A2. 
The eIF4A2 would then inhibit translation initiation by 
preventing the recruitment of active eIF4A1 (29). Further 
investigations are necessary to verify these models (30, 31). In 
addition, these Ago isoforms are expected to affect mRNA 
circularization through complex formation with trinucleotide 
repeat-containing protein 6 (TNRC6), which has the ability to 
repress translation (30, 31).
The gamma interferon-activated inhibitor of translation 
(GAIT) complex consists of a ribosomal protein L13a (rpL13a), 
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glyceraldehyde-3-phosphate dehydrogenase (GAPDH), glutamyl- 
prolyl-tRNA synthetase (EPRS), and NS1-associated protein-1 
(NSAP1), and represses translation initiation by inhibiting 
recruitment of the 43S translation initiation complex. The 
GAIT complex recognizes specific stem-loop structure elements 
and, in response to interferon-, forms on a subset of 3’-UTR 
elements of mRNAs, including those of ceruloplasmin and 
vascular endothelial growth factor (VEGF). mRNA circulari-
zation is maintained during GAIT-mediated repression of 
translation and is expected to contribute to the action of the 
3’-UTR binding protein complex on 5’-terminal cap-dependent 
translation initiation (32).
During female embryonic development in D. melanogaster, 
translation of mls2 mRNA is prevented by the Sex-lethal 
(SXL)/upstream of N-ras (UNR) complex formed on a specific 
cis-acting element in the 3’-UTR of mls2 mRNA. The SXL/UNR 
complex inhibits the recruitment of the 43S translation 
initiation complex by maintaining mRNA circularization (33). 
In addition, SXL binds to the 5’-UTR of mls2 mRNA and 
represses initiation codon scanning by the 43S initiation 
complex in an upstream open reading frame (uORF)-dependent 
manner (34).
Emerging evidence indicates that base modifications, 
including inosine, N6-methyladenosine (m6A), N1-methylade-
nosine, 5-methylcytosine, 5-hydroxymethylcytidine, and pseu-
douridine, can modulate the fate of mRNA (35). Among these 
modifications, m6A in 3’-UTRs promotes translation when 
recognized by YTH domain-containing family protein 1 
(YTHDF1) (36). Similarly, methyltransferase like 3 (METTL3), a 
catalytic subunit of the m6A methyltransferase complex, 
recognizes an un-methylated site of m6A and promotes 
translation (37). Although the precise mechanism needs to be 
elucidated, both YTHDF1 and METTL3 form a complex with 
components of the 43S translation initiation complex. 
Intriguingly, YTHDF2, another m6A decoder, competitively 
binds the same site and degrades mRNA (38). These 
complementary functions of m6A decoders could enable 
dynamic and precise regulation of gene expression. 
REGULATION OF TRANSLATION THROUGH 80S 
RIBOSOME ASSEMBLY (Fig. 2E)
During the differentiation of erythrocytes, the heterogeneous 
nuclear ribonucleic protein K (hnRNPK)/hnRNPE1 complex 
associates with a specific cis-acting element in the 3’-UTR of 
15-lipoxygenase mRNA. The hnRNPK/hnRNPE1 complex 
represses translation by inhibiting 60S ribosome binding to the 
43S initiation complex and assembly of the 80S ribosome (39). 
Translational repression during mRNA targeting coupled to 
local translation is essential for spatial restriction of protein 
production (40). In Saccharomyces cerevisiae, ASH1 mRNA, 
which encodes a repressor of mating-type switching, localizes 
to the tip of daughter cell. Translation of localizing ASH1 
mRNA is silenced by Pumilio-homology domain protein 6 
protein (Puf6p). Puf6p prevent assembly of 80S ribosomes on 
ASH1 mRNA. Puf6p recognizes a cis-acting element in the 
3’-UTR of ASH1 mRNA and binds yeast eIF5B. eIF5B is an 
essential component of 80S ribosome assembly; therefore, this 
RNA-dependent interaction is essential for translational 
repression of the ASH1 mRNA. Intriguingly, casein kinase 2 
(CK2)-mediated phosphorylation of Puf6p restores ASH1 
mRNA translation after mRNA localization (41). 
In mammals, Z-DNA-binding protein 1 (ZBP1) represses 
-actin mRNA translation through the inhibition of 80S 
assembly before its localization to the leading edge of cell 
migration. After mRNA localization, Src kinase-mediated phos-
phorylation of ZBP1 restores -actin mRNA translation (42).
REGULATION OF TRANSLATION THROUGH 
ELONGATION (Fig. 2F)
Phosphorylation-mediated regulation of translation through 
repression of RBPs plays a critical checkpoint coordinating the 
expression of transforming growth factor  (TGF)-induced 
epithelial-mesenchymal transition (EMT) transcripts in tumori-
genesis and metastatic progression. The hnRNPE1/eukaryotic 
elongation factor 1A (eEF1A) complex forms on specific 
cis-acting elements in the 3’-UTR of disabled-2 mRNA and 
interleukin-like EMT inducer (ILEI) mRNA. The hnRNPE1/eEF1A 
complex represses translation by associating with the 
translating 80S ribosome to “stall” on mRNA by preventing 
eEF1A dissociation from the 80S ribosome. Akt2, which is 
activated by TGF signaling, mediates phosphorylation of 
hnRNPE1 and induces hnRNPE1 dissociation from mRNA, 
thereby restoring translation of target mRNAs. Importantly, 
attenuation of hnRNP E1 expression induced EMT and enabled 
cells to form metastatic lesions in vivo (43). 
eEF1A dissociation-mediated translational repression is also 
used by Caenorhabditis elegans gld-1 mRNA. The FBF-1 
(nematode Pumilio)/CSR-1 (Ago isoform)/EFT-3 (nematode eEF1) 
complex forms on a specific cis-acting element in the 3’-UTR 
of gld-1 mRNA and represses translation (44).
REGULATION OF TRANSLATION THROUGH THE 
POLY(A) TAIL (Fig. 2G)
Many RBPs bound to 3’-UTRs of mRNAs induce mRNA 
degradation, although we do not discuss this in detail in this 
review (10). These RBPs associate with the deadenylase 
complex (e.g. poly(A)-specific ribonuclease (PARN), the 
poly(A) ribonuclease 2 (PAN2)/PAN3 complex and the carbon 
catabolite repression 4 (CCR4)–negative on TATA-less (NOT) 
complex) to enhance deadenylation (45). The terminal uridylyl 
transferases, TUT4 and TUT7, selectively recognize and 
catalyze uridylation of deadenylated mRNAs with short A-tails 
(＜ 25 nucleotides). This oligo uridylation enhanced the 
further degradation of the mRNA body (46). 
Deadenylation is thought to dissociate PABP from the 3’-tail 
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of mRNA and to disrupt mRNA circularization, thereby 
repressing translation. However, recent studies demonstrated 
that median poly(A) lengths are about 60-100 nucleotides (nt), 
which is shorter than the 150-200 nt thought to be typical of 
mammalian poly(A) tails. Poly(A) lengths of ＞ 20 nt are not 
correlated with translational efficiency in somatic cells (47, 
48). When the poly (A) tail length is ＜ 20 nt, translation is 
repressed in most genes in somatic cells (48). Because PABP 
binds to poly(A)s of 20 nt lengths, one PABP molecule might 
be sufficient to support mRNA circularization and 
poly(A)-dependent efficient translation. 
In contrast to somatic cells, poly(A) tail length and 
translational efficiency are coupled in embryonic cells (47, 
49). In X. laevis oocytes, cytoplasmic polyadenylation element 
binding protein (CPEB) binds specific cis-acting elements in 
the 3’-UTRs of mRNAs encoding cell cycle-related proteins, 
such as cyclin B. CPEB recruits PARN deadenylase and short 
poly(A) mRNAs are stabilized before oocyte maturation (50, 
51). The stimulation of oocyte maturation induces CPEB 
phosphorylation and promotes the association of cleavage and 
polyadenylation specificity factor (CPSF) and Germ Line 
Development 2 (GLD-2), poly (A) polymerase. Poly(A) elonga-
tion then augments translation of target mRNAs.
REGULATION OF mRNA DECAY THROUGH 
TRANSLATION
As mentioned above, the 3’-UTR plays a key role in 
translational control. However, reciprocally, translation also 
regulates 3’-UTR-mediated mRNA decay. For instance, when 
exon-junction complexes are bound to the 3’-UTR, premature 
translation termination is recognized, and the mRNA is 
degraded by the nonsense-mediated mRNA decay pathway 
which acts as an mRNA quality control system (52). Normal 
translation termination codon recognition also stimulates 
mRNA degradation of inflammation-related mRNAs containing 
a specific stem-loop in the 3’-UTR. In this case, the stem-loop 
is recognized by Regnase-1, an endonuclease (53). Similarly, 
translational termination induces the degradation of replication- 
dependent histone mRNAs and Staufen1-mediated mRNA 
decay (54, 55). An RNA helicase called Up frame shift 1 
(UPF1) is required for the translation-dependent mRNA decay 
systems described above. Taken together, 3’-UTRs can act 
bi-directionally in translational regulation and mRNA decay – 
mechanisms that are closely involved with each other.
PERSPECTIVES
In the present review, we briefly introduced the mechanism of 
translational control by mRNA 3’-UTR-binding proteins. 
Translational control is recognized as an essential regulatory 
mechanism of gene expression in various biological processes. 
For example, interferon- production from T-cells is regulated 
by translational control coupled with glycolysis. GAPDH, an 
enzyme essential for glycolysis, also acts as an RBP that 
directly binds to a cis-acting element in the 3’-UTR of the 
interferon- mRNA and acts as a translational repressor in 
inactive T cells. T cell activation drastically alters the 
metabolic status of T cells, with aerobic glycolysis promoted 
over oxidative phosphorylation, and GAPDH can dissociate 
from the interferon- mRNA to function as an aerobic 
glycolysis enzyme. In this situation, GAPDH no longer 
represses the translation of interferon- mRNA, leading to an 
increase in interferon- production (56). 
Many RBPs involved in translational control and/or mRNA 
degradation have additional roles in alternative pre-mRNA 
splicing, alternative poly(A) addition and other mRNA pro-
cessing events (57). In addition, analysis of translational 
control using plasmid vector-based reporter assays must 
consider the possibility of unexpected/undesired transcription 
from all regions of the circular plasmid DNA and unexpected 
processing of mRNA. Hence, in vitro reconstituted translation 
experiments should also be performed in addition to cell 
and/or animal-based analysis.
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